SCHEMBL24650797

SCHEMBL24650797

CCOC(=O)C1c2ccc(OCC)cc2CC1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
PPARD Q03181 1/20 0.42
TSHR P16473 1/20 0.41
KMT2A Q03164 2/20 0.41
PKM P14618 1/20 0.41
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
FFAR1 O14842 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24650775 0.90 ALOX15 (0.45) TSHRKMT2AALDH1A1KDM4EHPGD
SCHEMBL24650792 0.90 NQO2 (0.41) CHRNB2CHRNA4PPARDTSHRKMT2A
SCHEMBL24650831 0.90 CHRNB2 (0.43) CHRNB2CHRNA4PPARDKMT2ACA1
SCHEMBL24650827 0.87 PPARD (0.46) CHRNB2CHRNA4PPARDTSHRKMT2A
SCHEMBL24650772 0.84 KDM4E (0.40) TSHRKMT2ACA1CA2CA7
SCHEMBL24650273 0.81 BRD4 (0.41) CHRNB2CHRNA4PPARDKMT2APKM
SCHEMBL24651117 0.80 PPARD (0.43) CHRNB2CHRNA4PPARDCA1CA2
SCHEMBL24650855 0.80 MAPT (0.41) TSHRKMT2AALDH1A1KDM4EMAPT
SCHEMBL24650845 0.80 NQO2 (0.44) CHRNB2CHRNA4PPARDKMT2AALDH1A1
SCHEMBL24650763 0.80 ALDH1A1 (0.43) TSHRKMT2AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022238507-A1 THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS AWAKN LS EUROPE HOLDINGS LIMITED (IE) 2022-11-17 WO disclosed